BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8381965)

  • 1. Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.
    Coppes MJ; Liefers GJ; Paul P; Yeger H; Williams BR
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1416-9. PubMed ID: 8381965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
    Nordenskjöld A; Friedman E; Anvret M
    Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor.
    Tadokoro K; Fujii H; Ohshima A; Kakizawa Y; Shimizu K; Sakai A; Sumiyoshi K; Inoue T; Hayashi Y; Yamada M
    Oncogene; 1992 Jun; 7(6):1215-21. PubMed ID: 1350671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.
    Telerman A; Dodemont H; Degraef C; Galand P; Bauwens S; Van Oostveldt P; Amson RB
    Oncogene; 1992 Dec; 7(12):2545-8. PubMed ID: 1334252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.
    Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J
    FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S; Tomlinson G; Nisen P; Haber DA
    Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.
    Haber DA; Buckler AJ; Glaser T; Call KM; Pelletier J; Sohn RL; Douglass EC; Housman DE
    Cell; 1990 Jun; 61(7):1257-69. PubMed ID: 2163761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
    Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
    Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
    Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
    Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc finger point mutations within the WT1 gene in Wilms tumor patients.
    Little MH; Prosser J; Condie A; Smith PJ; Van Heyningen V; Hastie ND
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4791-5. PubMed ID: 1317572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
    Grubb GR; Yun K; Reeve AE; Eccles MR
    Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms' tumor alters gene function.
    Guan LS; Liu JJ; Xu YH; Wang ZY
    Cancer Res; 1998 Sep; 58(18):4180-4. PubMed ID: 9751632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine structure analysis of the WT1 gene in sporadic Wilms tumors.
    Varanasi R; Bardeesy N; Ghahremani M; Petruzzi MJ; Nowak N; Adam MA; Grundy P; Shows TB; Pelletier J
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3554-8. PubMed ID: 8170946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic analysis of chromosome 11p in familial Wilms tumour.
    Baird PN; Pritchard J; Cowell JK
    Br J Cancer; 1994 Jun; 69(6):1072-7. PubMed ID: 7911030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
    Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
    Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low frequency of mutations in the WT1 coding region in Wilms' tumor.
    Brown KW; Wilmore HP; Watson JE; Mott MG; Berry PJ; Maitland NJ
    Genes Chromosomes Cancer; 1993 Oct; 8(2):74-9. PubMed ID: 7504520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.